Spyre Therapeutics, Inc. · NASDAQ:SYRE

Sloan Sheldon sold 8,334 Spyre Therapeutics, Inc. shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 2, 2026

On Jul 1, 2026, Sloan Sheldon (Chief Medical Officer) sold 8,334 Spyre Therapeutics, Inc. shares at an average US$87.70 for US$731K under a trading plan, leaving 0 shares. Filed Jul 2, 2026 (Form 4).

Sold: 8,334 shares
Price: US$87.70 average (US$87.52 to US$88.34)
Value: US$731K
Holding after: 0 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Chief Medical Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jul 1, 2026	Common Stock	Option exercise	8,334	US$27.46	8,334	Direct
Jul 1, 2026	Common Stock	Sale	6,500	US$87.52	1,834	Direct
Jul 1, 2026	Common Stock	Sale	1,834	US$88.34	0	Direct

Source

View original at SEC

Related